扫描下面的二维码:

二维码

"中文幻灯"标签列表

POTENTIAL NEGATIVE IMPACT OF AGING ON HEPATOCARCINOGENESIS AFTER ANTI-VIRAL TREATMENT2008-04-30

PATHOPHYSIOLOGY OF PORTAL HYPERTENSION2008-04-30

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELA2008-04-30

HEPATOCELLULAR CARCINOMA 20082008-04-30

INTERFERON REGULATED GENE EXPRESSION IN THE LIVER DETERMINES RESPONSE TO TREATMENT IN CHRONIC HEPATI2008-04-30

HEMODYNAMIC EFFECTS AND SAFETY OF ONE-MONTH SIMVASTATIN TREATMENT2008-04-30

Hepatitis B THE Problem of drug resistance2008-04-30

HBX BINDS IN VIVO ON THE HBV MINICHROMOSOME, MODIFIES THE EPIGENETIC REGULATION OF CCC-DNA FUNCTION 2008-04-30

HBV LIFE CYCLE CAN WE FIND NOVEL ANTIVIRAL TARGETS2008-04-30

FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND W2008-04-30

EXHAUSTION AND FUNCTIONAL RESTORATION OF INTRAHEPATIC HBV SPECIFIC T CELLS IN CHRONIC HEPATITIS B2008-04-30

EFFICAY AND SAFETY OF PEGYLATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS AWAITING LIVER TRA2008-04-30

CYTOPROTECTIVE EFFECTS OF EXENDIN-4, A GLP-1 RECEPTOR AGONIST, ON THE BILIARY THELIUM2008-04-30

Molecular genetics of intrahepatic cholestasis2008-04-30

Autoimmune hepatitis2008-04-30

Coagulopathy and coagulation tests in cirrhosis2008-04-30

Portal pressure and new strategies for prophylaxis of variceal bleeding2008-04-30

Tailored therapy for chronic hepatitis B2008-04-30

Chronic Hepatitis B, who should be treated?: debate between experts2008-04-30

Antiviral therapy for HBV: is it really cost-effective?2008-04-30

推荐标签 更多 >>

栏目标签

领域标签



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计